- Poster presentation
- Open Access
Thermal ablation of a confluent lesion in the porcine kidney with magnetic resonance guided high intensity focused ultrasound
© van Breugel et al; licensee BioMed Central Ltd. 2015
- Published: 30 June 2015
- Renal Mass
- Thermal Ablation
- Nicotinamide Adenine Dinucleotide
- High Intensity Focus Ultrasound
- Ablation Cell
Since approximately 1.6 percent of men and women will be diagnosed with kidney and renal pelvis cancer during their lifetime, there is a growing interest in non-invasive kidney sparing therapy for renal cancer. As a consequence, several patient studies investigated the feasibility of high intensity focused ultrasound (HIFU) for the thermal ablation of renal masses. The majority of these studies used either a hand-held extracorporeal ultrasound transducer with ultrasound imaging for guidance or a laparoscopic approach. Drawbacks of these techniques are the lack of respiratory motion compensation, no means to observe the energy deposition in real time, the complexity of the probe positioning, and the risks of bleeding and tumor spillage. Alternatively, recent preclinical studies have demonstrated the feasibility of magnetic resonance guided high intensity focused ultrasound (MR-HIFU) interventions on the kidney with respect to motion compensated real-time thermometry and acoustic energy delivery. Here, we extend this prior work to investigate in an animal study if MR-HIFU can deliver a reliable confluent volumetric lesion in the renal cortex in a clinically relevant time-frame.
This study was performed within the framework of CTMM, the Center for Translational Molecular Medicine, project VOLTA (grant 05T-201).
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.